You mean a trial enrollment away? TBH it would have been better to do a 100-200 patient phase II for CD12 in retrospect; we would've found out in Nov that critical was the real meat, and done a critical PIII and probably fully enrolled it by now.

Just sucks it's delayed. God forbid P.1 starts getting a foothold, or the Cali / NYC strains get that bad.